Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain
Go back to Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain| (NASDAQ: ALZN) | Delayed: 1.68 +0.02 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.66 | 52 Week High | $ | |||
| Open | $1.66 | 52 Week Low | $ | |||
| Day High | $1.72 | P/E | N/A | |||
| Day Low | $1.62 | EPS | $ | |||
| Volume | 31,191 | |||||
